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Abstract
Background: Previous studies showed that left atrial enlargement is an independent marker of adverse outcomes in
both primary and secondary cardiovascular prevention. However, no data are available on long-term outcomes in
patients undergoing valve surgery and/or coronary artery by-pass graft (CABG) surgery. Aim of the study was to
evaluate long-term prognostic role of left atrial volume index (LAVi) after cardiac surgery, using the cutoff values
recently proposed by the European Association of Cardiovascular Imaging and American Society of Echocardiography.
Methods: We created a retrospective registry of 1703 consecutive patients who underwent cardiovascular
rehabilitation program after cardiac surgery, including CABG, valve surgery and valve + CABG surgery. LAVi was
calculated as ratio of left atrium volume to body surface area, in ml/m2 at discharge; 563 patients with available LAVi
data were included in the study.
Results: In the whole population LAVi was 36 ± 14 ml/m2 (mean ± SD) and the follow-up time was 5 ± 1.
5 years. Increased LAVi (>34 ml/m2) predicted major adverse cardiovascular and cerebrovascular events
(MACCEs) (HR = 2.1; CI95 %: 1.4–3.1; p < 0.001) and cardiovascular mortality (HR = 2.2; CI95 %: 1.0–4.5; p = 0.032).
An increased LAVi remained MACCEs predictor after adjustement for age, gender, diabetes, atrial fibrillation at
discharge, echocardiographic E/A ratio and left ventricular ejection fraction (HR = 1.8; CI95 %: 1.0–3.0; p = 0.
036). When the study population was split according to increasing LAVi values, left atrium enlargement
resulted a predictor of progressively worse adverse outcome.
Conclusions: LAVi is a predictor of long-term adverse cardiovascular outcome after cardiac surgery, even after
correction for main clinical and echocardiographic variables. The recently recommended LAVi severity cutoffs
appear adequate to effectively stratify outcome in patients undergoing rehabilitation after cardiac surgery.
Keywords: Left atrial volume index, Coronary artery by-pass graft, Cardiac valve surgery, Echocardiography,
cardiovascular outcomes
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Background
Left atrium (LA) modulates left ventricular (LV) filling
and cardiovascular performance by functioning as a reser-
voir and a conduit for pulmonary venous return and as a
“booster” that augments ventricular filling during late ven-
tricular diastole. LA also reflects LV filling pressure and is
capable of remodeling (enlarging) in response to its eleva-
tion [1, 2]. Although there is a growing body of evidence
demonstrating that LA enlargement is an independent
marker of adverse outcomes both in primary [3–7] and
secondary [8–11] cardiovascular prevention, to date, there
are no published data assessing long-term outcome in pa-
tients undergoing valve and coronary artery by-pass graft
(CABG) surgery.
Aim of this retrospective study was to examine long-
term prognostic implications of left atrial volume index
(LAVi) assessment in patients undergoing cardiovascular
rehabilitation program (CRP) after cardiac surgery, using
the cutoff values proposed by the recently-published
guidelines of the European Association of Cardiovascu-




We created a registry of consecutive patients undergoing
cardiovascular rehabilitation program (CRP) after cardiac
surgery, including CABG, valve surgery and combined
valve and CABG surgery, from January 2007 to June 2012.
A total of 1703 subjects (70 % men, mean age of 69 ±
11 years) were collected and, out of them, all 563 patients
with available biplane left atrial volume data were extracted
for the current analysis. The internal review board of Fon-
dazione Don Gnocchi approved data collection. All pa-
tients completed a standard in-hospital CRP, lasting
approximately 2 weeks, consisting of supervised exercise
sessions (120 min per day), lifestyle and risk factor manage-
ment, medical counseling and medical therapy
optimization. For each patient we collected variables from
medical record including anamnestic and demographic
findings, clinical and laboratory markers, electrocardio-
graphic and echocardiographic measurements, physical
activity data, pharmacological therapy adherence. Out-
comes were collected through a telephonic questionnaire
administered by a medical doctor or a supervised fellow
and all patients provided oral informed consent. End
points were: overall mortality and major adverse cardiovas-
cular and cerebrovascular events (MACCEs) defined as ei-
ther: cardiovascular (CV) mortality, non-fatal acute
coronary syndrome (ACS), heart failure (HF) and stroke.
Echocardiographic data
M-mode and 2-dimensional echocardiographic images
were obtained with a commercially available
echocardiography machine (Esaote MyLab™ 60). LA
volume was calculated using the biplane area-length
method at discharge of CRP [12]. Measurements were
obtained in end-systole from the frame preceding mi-
tral valve opening. LAVi was calculated as the ratio of
LA volume to body surface area (ml/m2). In agree-
ment with ASE and EACVI guidelines, we assumed
LAVi > 34 ml/m2 as the LA enlargement threshold
and we further classified LAVi values from 35 to
41 ml/ m2 as mild LA enlargement, from 42 to
48 ml/ m2 as moderate LA enlargement and greater
than 48 ml/ m2 as severe enlargement [12].
Statistical analysis
Continuous variables were expressed as mean (M) and
standard deviation (SD), categorical variables as number
(N) and percentage (%). The Student 2-sample t test,
Pearson χ2 test, Mann–Whitney–Wilcoxon rank-sum
test were used to compare the differences between
groups for continuous, categorical and ordinal variables,
respectively. Cox proportional hazard regression analysis
was performed to create survival-free-from-event curves.
Multivariate Cox regression analysis was used to create
adjustment of hazard ratio (HR) for age, left ventricular
ejection fraction (LVEF), gender, diabetes, and ratio of
the early (E) to late (A) ventricular filling velocities (E/A
ratio). Event-free survival analysis was measured from
admission to the first event. Significance was defined as
a p value <0.05. All statistics were performed with SPSS
version 21 (IBM Corporation).
Results
Demographic and clinical characteristics
A total of 563 patients were included in the study. Mean
age was 69 ± 10 years and male gender was prevalent,
with 399 males (70 %). 149 patients (26 %) were affected
by type 2 diabetes and 305 patients (54 %) by arterial
hypertension. 292 patients (52 %) underwent CABG, 191
(34 %) valve surgery, 80 (14 %) combined valve and
CABG surgery.
One hundred and eighty-four patients (33 %) under-
went cardiac revascularization after ACS and 98 (18 %)
after stable angina or silent ischemia; 100 patients (18 %)
were affected by mitral valve regurgitation, 9 (2 %) by
mitral valve stenosis, 73 (13 %) by aortic valve stenosis
and 41 (7 %) by aortic valve regurgitation. LAVi and
LVEF mean values over the whole group of patients were
36 ± 14 ml/m2 and 51 ± 9 %, respectively.
LA enlargement was found in 257 patients (46 %), 97
(17 %) patients with mild LA enlargement, 71 (13 %)
with moderate LA enlargement and 89 (16 %) with
severe LA enlargement.
Patients with LA enlargement were significantly older
compared with patients with normal LA (71 ± 9 vs 68 ±
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10 years, <p = 0.001). A higher prevalence of normal LA
was observed in the subgroup of patients with estab-
lished coronary artery disease such as prior acute coron-
ary syndrome (normal LA 63 % vs LA enlargement
37 %; p = 0.001) or stable angina (normal LA 67 % vs LA
enlargement 33 %; p = 0.002). Conversely, LA enlarge-
ment was more frequent in the subgroup of patients
with mitral regurgitation (normal LA 44 % vs LA en-
largement 56 %; p = 0.034) and aortic stenosis (normal
LA 32 % vs LA enlargement 68 %; p < 0.001). Mean
LVEF was significantly lower in patients with LAVi >
34 ml/m2 in comparison to the group with normal LAVi
(49 ± 10 % vs 52 ± 9 %; p < 0.005). Sinus rhythm rate at
discharge was higher in patients with normal LAVi
(59 % vs 41 %; p < 0.01) and no differences in the use of
beta-blockers (52 % vs 48 %; p = n.s.) and amiodarone
(51 % vs 49 %; p = n.s.) were found between normal
LAVi and LAVi enlargement; conversely, statins and
ace-inhibitors administration was higher in patients with
normal LAVi (56 % vs 44 %; p < 0.01 and 57 % vs 43 %;
p < 0.01 respectively).
Table 1 shows differences in baseline parameters
between normal LA and LA enlargement.
End point
Mean follow-up was 5 ± 1.5 years. All-cause mortality
consisted in 55 deaths (10 %) and the total amount of
MACCEs was 114 (20 %), composed by 31 CV deaths
(5 %), 43 HF hospitalization (8 %), 15 strokes (3 %) and
25 ACS (4 %).
MACCEs were 2.1-fold higher in patients with LAVi >
34 ml/m2 compared with patients with normal LA vol-
ume, this difference being significant even considering
patients who received CABG or valve surgery separately
(in particular in patients with mitral and aortic regurgi-
tation; see Table 2). Moreover, event-free survival from
MACCEs was significantly lower in both patients who
underwent CABG and valve surgery with enlarged LA
(Fig. 1).
By dividing the whole population according to se-
verity partition cut-offs, MACCEs rate was signifi-
cantly higher in patients with either moderate or
severe LA enlargement but not in those with mild
LA enlargement (Fig. 2 and Table 2). Multivariate
analysis, adjusted for age, gender, diabetes, E/A, atrial
fibrillation at discharge and LVEF, confirmed the role
of LA enlargement in predicting MACCEs in the
whole population; moreover, the progressive increase
of LAVi severity maintained an incremental risk of
MACCEs in patients with LA enlargement ranging
from moderate to severe (Fig. 3).
Severe LA enlargement resulted a significant and ro-
bust predictor of any type of secondary end point: all-
cause mortality, CV mortality, HF and stroke. In patients
with moderate LA enlargement, HF rate was 2.5-fold
higher in comparison with normal LA size group.




(LAVi > 34 ml/m2)
N = 306 N = 257
Age (years) 68 (10) 71 (9)**
Male sex 245 (61) 154 (39)**
BMI (kg/m2) 26.9 (4) 26.7 (4)
BSA (m2) 1.9 (0.2) 1.8 (0.2)**
CV risk Factors
Familiar history (CVD) 159 (56) 120 (44)
AHT 159 (52) 146 (48)
DM 83 (55) 66 (45)
Dyslipidaemia 165 (57) 120 (43)
Types of cardiac surgery
CABG 197 (75) 95 (25)**
Heart-valve surgery 73 (25) 118 (75)**
CABG + Valve surgery 37 (46) 43 (54)
Clinical indications
ACS 116 (63) 68 (37)*
Stable Angina 66 (67) 32 (33)*
MV Stenosis 2 (22) 7 (78)
MV regurgitation 44 (44) 56 (56)*
AV Stenosis 23 (32) 20 (68)**
AV regurgitation 19 (46) 22 (54)
Other indication 36 (62) 22 (38)
Echocardiographic parameters
LAV (ml) 49 (11) 85 (22)**
LAd (mm) 38 (5) 54 (6)**
LVEF (%) 52 (9) 49 (10)*
LV EDV (ml) 105 (41) 108 (42)
IVS (mm) 12 (2) 13 (2)**
E/A Ratio 1 (0.4) 1 (0.6)
Medications
β-Blocker 201 (52) 185 (48)
Amiodarone 79 (51) 77 (49)
OAT 72 (38) 117 (62)**
ACEi 216 (57) 170 (43)**
Statins 218 (56) 168 (44)**
Values are expressed as mean and standard deviation or as number
and percentage
LA left atrium; LAVi left atrial volume index; BMI body mass index; CVD
cardiovascular disease; AHT arterial hypertension; DM diabetes mellitus; CABG
coronary artery bypass graft; ACS acute coronary syndrome; MV mitral valve;
AV aortic valve; Lad left atrium antero-posteior diameter; LVEF left ventricular
ejection fraction; IVSs interventricular septum; LV EDV left ventricular end-
diastolic volume; OAT oral anticoagulant therapy
*and **indicate differences at significance levels p <0.05 and p <0.01 respectively
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Outcomes of patients with normal LAVi and with mild
LA enlargement did not differ (Table 2).
Cardiovascular mortality rate was 2.2-fold higher in
patients with LAVi > 34 ml/m2. Event-free survival
from cardiovascular mortality was significantly lower
in these patients (Fig. 4), whilst only a trend towards
a higher all-cause mortality was found in patients
with LAVi > 34 ml/m2 (Table 2).
Discussion
The present study demonstrates, in a population of
563 patients followed for about 5 years after cardiac
surgery, that post-operative LAVi is a long-term pre-
dictor of MACCEs and CV mortality, also confirming
its prognostic value in predicting MACCEs even after
adjustment for age, gender, diabetes, atrial fibrillation
at discharge, E/A diastolic index and LVEF.
Left atrium reflects left ventricular filling pressure, a
parameter conditioned by structural and functional
heart impairement [1, 2]. Consequentely, LA enlarge-
ment is an echocardiographic marker that mirrors left
ventricular systolic and/or diastolic chronic dysfunc-
tion, representing a possible pathophysiological ex-
planation of our results.
Previous studies in patients undergoing cardiac sur-
gery only examined the relationship between LA vol-
ume and prevalence of either post-operative atrial
fibrillation [13] or symptomatic improvement of HF
Table 2 HR for primary and secondary end points by univariate Cox proportional hazard regression analysis
LA severity partition cut-off
LA enlargement (LAVi > 34 ml/m2) Mild LA enlargement Moderate LA enlargement Severe LA enlargement
MACCEs HR (95 % CI) p HR (95 % CI) p HR (95 % CI) p HR (95 % CI) p
All Patients 2.1 (1.4–3.1) 0.000# 1.2 (0.7–2.2) 0.457 2.2 (1.3–2.7) 0.003* 3.1 (2.0–4.9) 0.000#
CABG Patients 2.1 (1.3–3.2) 0.001* 1.8 (0.7–4.5) 0.201 3.2 (1.2–7.9) 0.013* 6.1 (2.6–14.1) 0.000#
Valve Patients 2.7 (1.2–6.0) 0.011* 1.6 (0.5–4.9) 0.402 2.9 (1.1–7.7) 0.025* 3.3 (1.4–8.0) 0.005#
Aortic stenosis 6.6 (0.8–51) 0.071 0.1 (0.1–1.0) 0.521 1.9 (0.3–11) 0.482 1.6 (0.2–9.6) 0.060
Aortic regurgitation 4.2 (1.5–11) 0.004* 3.3 (0.7–15) 0.117 3.7 (1.1–12) 0.028* 4.5 (1.5–13) 0.006*
Mitral regurgitaton 4.2 (1.5–11) 0.004* 1.9 (0.1–31) 0.638 6.4 (0.7–57) 0.096 7.0 (0.9–57) 0.067
Valve + CABG 2.3 (0.9–5.6) 0.053 1.6 (0.4–6.3) 0.484 2.4 (0.7–7.8) 0.122 2.6 (0.9–7.1) 0.050
All-cause mortality 1.6 (0.9–2.8) 0.064 1.2 (0.5–2.7) 0.533 1.6 (0.7–3.5) 0.258 2.2 (1.1–4.2) 0.025*
CV mortality 2.2 (1.0–4.5) 0.032* 1.2 (0.4–3.7) 0.739 2.5 (0.9–6.6) 0.070 3.1 (1.3–7.4) 0.010*
Heart failure 1.8 (0.9–3.5) 0.057 0.8 (0.2–2.5) 0.796 2.5 (1.0–5.8) 0.034* 2.5 (1.1–5.4) 0.023*
Stroke 1.6 (0.5–4.8) 0.327 1.0 (0.2–5.3) 0.918 n.a. n.a. 3.8 (1.2–11.9) 0.019*
n.a.
ACS 1.9 (0.8–4.4) 0.137 1.5 (0.4–4.9) 0.492 1.6 (0.4–5.9) 0.483 2.6 (0.9–7.4) 0.067
MACCEs major adverse cardiovascular and cerebrovascular events; LA left atrial; LAVi left atrial volume index; HR hazard ratio; CI confidence interval; CABG coronary
artery by-pass graft; Valve valve surgery; CV cardiovascular; ACS acute coronary syndrome; n.a not applicable (no event)
P value: difference in comparison with normal LAVi group (≤34 ml/m2) * p < 0.05; # p < 0.001
Fig. 1 Left: LA enlargement and survival free from MACCEs in CABG patients. Right: LA enlargement and survival free from MACCEs in valve surgery
patients. MACCEs, major adverse cardiovascular and cerebrovascular events; LA, left atrium
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[14]. Therefore, our results offer novel data highlighting a
significant prognostic role of LAVi on MACCEs and CV
mortality in such patients. In addition, our study repre-
sents a convincing validation of the prognostic signifi-
cance of the new severity partition cutoffs, suggested by
both EACVI and ASE [12], in patients undergoing cardiac
surgery. In particular, we showed that moderate and se-
vere LA enlargement is associated with increased rate of
MACCEs, while mildly increased LAVi represents a grey
zone which does not appear to robustly impact the
prognosis.
LA size is a recognized prognostic predictor in pri-
mary CV prevention. This was demonstrated in a 8-
year follow-up of 5209 individuals included in the
Framingham Heart Study, where an increased LA
diameter was associated with higher risk of stroke
and mortality [15] and other primary prevention stud-
ies suggested the independent role of LAVi in predict-
ing CV death [3, 5, 7], MACCEs [5, 7], ischemic
stroke [6] and atrial fibrillation [4].
The prognostic significance of LAVi has been con-
firmed also in secondary CV prevention, especially in
patients after acute myocardial infarction (MI). An in-
creased LA volume, assessed within the first 48 h of
admission, independently predicted 5-year mortality in
a population of 395 MI patients [8]. Similarly, LAVi
>32 ml/m2 did result an independent predictor of
mortality during a mean follow-up of 15 months in
314 MI patients [16], being these results thereafter
confirmed in a population of 610 subjects with high-
risk MI followed for a mean of 20 months [9]. The
relationship between LAVi and CV outcomes was also
addressed in 935 outpatients with established coronary ar-
tery disease followed for about 4 years, concluding that
LAVi was similar to LVEF in predicting mortality and HF
hospitalization [17].
The prognostic implications of LA size were con-
firmed also in patients with valve disease, who did or
did not undergo cardiac surgery. Neverthless, the ma-
jority of these studies has been mainly focused on
post-operative atrial fibrillation [13, 18, 19], LVEF re-
covery [20] and HF symptoms [14], while harder end-
points, such as cardiovascular mortality, had only
been evaluated in 176 patients with symptomatic
chronic mitral regurgitation undergoing valve replace-
ment by using pre-operative LA diameter [21].
Given that in previous studies the predictive signifi-
cance of LA size was invariably investigated measur-
ing LA diameter or LAVi with either arbitrary or
single cutoff value, our study could represent the first
prognostic validation of the new three cutoffs of se-
verity partition, recently recommended by both
EACVI and ASE. Our results highlight the import-
ance to quantify the LA size in terms of LAVi; they
also suggest that LAVi should be measured not only
in routine clinical practice but also in a rehabilitation
setting for more accurate risk-stratification and
clinical decision making in patients who underwent
cardiac surgery.
Fig. 2 MACCEs and LA severity partition cut-offs after cardiac surgery.
MACCEs, major adverse cardiovascular and cerebrovascular events; LA,
left atrium
Fig. 3 Hazard Ratio with 95 % CI for MACCEs calculated after
adjustment for age, LVEF, gender, diabetes, atrial fibrillation at discharge
and E/A ratio, in subgroups of patients with mild, moderate and severe
LA enlargement, and in all patients with LA enlargement; * and **
indicate significant differences from HR= 1 at p< 0.05 and p< 0.01
significance levels
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Study limitations
The entry criterion for the study was the availability
of LAVi measurement and in our registry of 1703
patients, only 563 had such data available for analysis;
this approach, driven by the absence of a protocol for
LA measurement using LAVi, may have introduced a
selection bias.
Although this intrinsic bias could not reflect the real
prevalence of LA dimension in the whole population,
the rate of LA enlargement, assessed in the entire cohort
with LA diameter (cut-off 40 mm), was similar to that
evaluated in the subgroup of patients with available bi-
plane left LA volume data (46 % of LA enlargement
using LAVi and 48 % using LA dimeter).
Given the retrospective nature of the study, LAVi mea-
surements were obtained by multiple observers working
in the same clinical environment and using the same
echo machine. This may have created an inter-observer
bias related to the variability of the measurements; on
the other hand our results would suggest that the prog-
nostic significance of LAVi can be widely applied in the
clinical setting.
Conclusions
Increased post-operative LAVi represents a predictor of
adverse outcome after cardiac surgery and provides prog-
nostic information, importantly incremental to several
conventional risk factors. The recently recommended
LAVi severity cutoffs appear adequate to effectively stratify
outcome in patients undergoing rehabilitation after car-
diac surgery. These results should be verified trough a
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